Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...
Discover a study exploring how high serum TSLP influences adult asthma and implications for targeted treatment.
Serum urate (SU) levels rise sharply during the menopausal transition and remain elevated thereafter, suggesting that the risk for hyperuricemia and subsequent gout among women may begin years before ...
Travere Therapeutics, Inc., today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® (sparsentan) were ...
With close to a decade of writing and editing experience, Maisha specializes in service journalism and has produced work in the lifestyle, financial services, real estate, and culture spaces. She uses ...
Important Disclosure: The content provided does not consider your particular circumstances and does not constitute personal advice. Some of the products promoted are from our affiliate partners from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback